BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24051083)

  • 1. Evaluation of the Simplified Comorbidity Score (Colinet) as a prognostic indicator for patients with lung cancer: a cancer registry study.
    Ball D; Thursfield V; Irving L; Mitchell P; Richardson G; Torn-Broers Y; Wright G; Giles G
    Lung Cancer; 2013 Nov; 82(2):358-61. PubMed ID: 24051083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma.
    Kuo YW; Jerng JS; Shih JY; Chen KY; Yu CJ; Yang PC
    J Thorac Oncol; 2011 Feb; 6(2):378-83. PubMed ID: 21173715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N; Pedersen LM
    Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
    Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
    Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Comorbidity and the Simplified Comorbidity Score on Overall Survival in Non-Small Cell Lung Cancer-A Prospective Cohort Study.
    Alexander M; Evans SM; Stirling RG; Wolfe R; Officer A; MacManus M; Solomon B; Burbury K; Ball D
    J Thorac Oncol; 2016 May; 11(5):748-757. PubMed ID: 26851495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index.
    Colinet B; Jacot W; Bertrand D; Lacombe S; Bozonnat MC; Daurès JP; Pujol JL;
    Br J Cancer; 2005 Nov; 93(10):1098-105. PubMed ID: 16234816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
    Aarts MJ; Aerts JG; van den Borne BE; Biesma B; Lemmens VE; Kloover JS
    Clin Lung Cancer; 2015 Jul; 16(4):282-91. PubMed ID: 25572007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced non-small cell lung cancer in the elderly: the impact of age and comorbidities on treatment modalities and patient prognosis.
    Hsu CL; Chen JH; Chen KY; Shih JY; Yang JC; Yu CJ; Yang PC
    J Geriatr Oncol; 2015 Jan; 6(1):38-45. PubMed ID: 25245172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
    Singh N; Singh PS; Aggarwal AN; Behera D
    Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
    Kocher F; Hilbe W; Seeber A; Pircher A; Schmid T; Greil R; Auberger J; Nevinny-Stickel M; Sterlacci W; Tzankov A; Jamnig H; Kohler K; Zabernigg A; Frötscher J; Oberaigner W; Fiegl M
    Lung Cancer; 2015 Feb; 87(2):193-200. PubMed ID: 25564398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic position and surgery for early-stage non-small-cell lung cancer: A population-based study in Denmark.
    Kærgaard Starr L; Osler M; Steding-Jessen M; Lidegaard Frederiksen B; Jakobsen E; Østerlind K; Schüz J; Johansen C; Oksbjerg Dalton S
    Lung Cancer; 2013 Mar; 79(3):262-9. PubMed ID: 23276505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival.
    Milano MT; Zhang H; Usuki KY; Singh DP; Chen Y
    Cancer; 2012 Nov; 118(22):5572-9. PubMed ID: 22544655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer.
    Holdenrieder S; Von Pawel J; Duell T; Feldmann K; Raith H; Schollen A; Nagel D; Stieber P
    Anticancer Res; 2010 May; 30(5):1855-62. PubMed ID: 20592392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.
    Di Maio M; Lama N; Morabito A; Smit EF; Georgoulias V; Takeda K; Quoix E; Hatzidaki D; Wachters FM; Gebbia V; Tsai CM; Camps C; Schuette W; Chiodini P; Piccirillo MC; Perrone F; Gallo C; Gridelli C
    Eur J Cancer; 2010 Mar; 46(4):735-43. PubMed ID: 20045311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for patients with spinal metastases from lung cancer.
    Ogihara S; Seichi A; Hozumi T; Oka H; Ieki R; Nakamura K; Kondoh T
    Spine (Phila Pa 1976); 2006 Jun; 31(14):1585-90. PubMed ID: 16778693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in non-small cell lung cancer: a population-based study.
    Caldarella A; Crocetti E; Comin CE; Janni A; Pegna AL; Paci E
    Eur J Surg Oncol; 2007 Aug; 33(6):763-8. PubMed ID: 17306497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
    Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
    Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.